For the quarter ending 2026-03-31, APVO has $19,902K in assets. $8,290K in debts. $14,525K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 14,525 | 21,619 | 21,061 | 9,410 |
| Prepaid expenses | - | - | 1,511 | 1,589 |
| Other current assets | - | - | 77 | 82 |
| Prepaid expenses and other current assets | 1,459 | 1,462 | - | - |
| Total current assets | 15,984 | 23,081 | 22,649 | 11,081 |
| Property and equipment, gross | - | 14,446 | - | - |
| Less accumulated depreciation | - | 14,143 | - | - |
| Property and equipment, net | 268 | 303 | 384 | 432 |
| Operating lease right-of-use asset | 3,650 | 3,810 | 3,963 | 4,111 |
| Total assets | 19,902 | 27,194 | 26,996 | 15,624 |
| Accounts payable | 890 | 877 | - | - |
| Accounts payable and other accrued liabilities | - | - | 2,219 | 2,903 |
| Accrued compensation | - | - | 1,901 | 1,040 |
| Accrued expenses and other current liabilities | 2,977 | 4,307 | - | - |
| Other current liabilities | - | - | 1,494 | 948 |
| Operating lease liability, current portion | 892 | 866 | - | - |
| Total current liabilities | 4,760 | 6,050 | 5,614 | 4,891 |
| Operating lease liability, current portion | 3,530 | 3,763 | 3,990 | 4,209 |
| Total liabilities | 8,290 | 9,813 | 9,604 | 9,100 |
| Common stock 0.001 par value 500,000,000 shares authorized 1,203,753 and 997,830 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 114 | 114 | 110 | 99 |
| Additional paid-in capital | 293,407 | 292,382 | 286,499 | 266,614 |
| Accumulated deficit | -281,909 | -275,115 | -269,217 | -260,189 |
| Total stockholders' equity | 11,612 | 17,381 | 17,392 | 6,524 |
| Total liabilities and stockholders' equity | 19,902 | 27,194 | 26,996 | 15,624 |
Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics Inc. (APVO)